Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III studyVito Lorusso, Giuseppe Colucci, Vittorio Gebbia et al.|International Journal of Oncology|2014Cited by 26
A multicenter randomized phase III trial of nonpegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide (MC) versus liposome-encapsulated doxorubicin citrate plus vinorelbine (MV) as first-line treatment in locally advanced (LABC) or metastatic breast cancer (MBC).Vito Lorusso, Giuseppe Colucci, Francesco Giotta et al.|Journal of Clinical Oncology|2011Cited by 0
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Laura Orlando, Palma Fedele et al.|The Breast Journal|2020Cited by 0